A clinical study to treat hyperpigmentation by using Chinchadi lepa

A Randomized open labelled controlled clinical study to evaluate the efficacy of Chinchadi lepa in the management of Vyanga with special reference to Melasma.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054761

Enrollment

15000

Registered

2023-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: Chinchadi Lepa: The subjects will be asked to wash the face and dry it completely with a clean cloth. Chinchadi Lepa will be given and asked to apply quantity sufficient of lepa as thin

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of either gender with the age group between 21-60 years. Subjects fulfilling the diagnostic criteria of Vyanga with special reference to Melasma will be randomly selected, irrespective of their religion, occupation and socio-economic status.

Exclusion criteria

Exclusion criteria: Female on oral contraceptive pills, pregnant women and lactating women. Subjects who are on any hormonal therapy. Subjects who are known hyperpigmentation since birth. Subjects who are known inflammatory pigmentation. Subjects who are known malignant melanoma. Any other condition interfering with the course of the treatment.

Design outcomes

Primary

Measure	Time frame
Reduction of hyperpigmentationTimepoint: One year.	—

Secondary

Measure	Time frame
Complexion improvementTimepoint: One year	—

Countries

India

Contacts

Public ContactDr Bhavana H N

Sri Sri College of Ayurvedic Science and Research Bengaluru

drmaheshcd@yahoo.co.in9986303884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026